Oculistics pharmaceutical composition for cataract treatment

Details Oculistics pharmaceutical composition for cataract treatment Oculistics pharmaceutical composition for cataract treatment

1987-06-12

1989-09-26

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514913, 514556, A61K 31195

Patent

active

048701068

ABSTRACT:
This invention relates to a pharmaceuticals which contains thyroid hormones and improved method which extracts thyroid hormones from animal thyroid gland. The pharmaceuticals of this invention is used to treat senile cortical cataract. There are some effect of long term on other cataract except subcapsular cataract. The pharmaceuticals of this invention is applied in the form of eyedrops or injection.

REFERENCES:
patent: 3455894 (1969-07-01), Hoover et al.
patent: 3674770 (1972-07-01), Hoover et al.
patent: 3705142 (1972-12-01), Turner
Craig, Charles R. and Robert Stitzel, Modern Pharmacology, Little, Brown and Company, Boston, 1982, pp. 862-865.
Gross, J. and Rosalind Pitt-Rivers, "3:5:3'-Triiodothyronine", Biochem. J. 53:645 (1953).

Affiliated with

Also associated with

Rating

Oculistics pharmaceutical composition for cataract treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oculistics pharmaceutical composition for cataract treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oculistics pharmaceutical composition for cataract treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-188047